Cardiff Oncology, Inc. (CRDF)
1.02
+0.02
(+2.20%)
USD |
NASDAQ |
Aug 25, 12:29
Cardiff Oncology Market Cap : 69.87M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 68.36M |
| August 21, 2026 | 60.29M |
| August 20, 2026 | 62.25M |
| August 19, 2026 | 61.51M |
| August 18, 2026 | 60.70M |
| August 17, 2026 | 61.95M |
| August 14, 2026 | 65.97M |
| August 13, 2026 | 67.41M |
| August 12, 2026 | 67.85M |
| August 11, 2026 | 71.93M |
| August 10, 2026 | 70.56M |
| August 07, 2026 | 67.95M |
| August 06, 2026 | 65.66M |
| August 05, 2026 | 65.29M |
| August 04, 2026 | 63.51M |
| August 03, 2026 | 63.86M |
| July 31, 2026 | 58.48M |
| July 30, 2026 | 58.18M |
| July 29, 2026 | 55.38M |
| July 28, 2026 | 55.93M |
| July 27, 2026 | 57.15M |
| July 24, 2026 | 56.54M |
| July 23, 2026 | 57.30M |
| July 22, 2026 | 58.80M |
| July 21, 2026 | 57.43M |
| Date | Value |
|---|---|
| July 20, 2026 | 57.34M |
| July 17, 2026 | 60.17M |
| July 16, 2026 | 59.79M |
| July 15, 2026 | 60.80M |
| July 14, 2026 | 89.56M |
| July 13, 2026 | 92.30M |
| July 10, 2026 | 90.93M |
| July 09, 2026 | 90.25M |
| July 08, 2026 | 85.46M |
| July 07, 2026 | 92.30M |
| July 06, 2026 | 88.88M |
| July 02, 2026 | 86.83M |
| July 01, 2026 | 88.20M |
| June 30, 2026 | 88.88M |
| June 29, 2026 | 86.83M |
| June 26, 2026 | 85.46M |
| June 25, 2026 | 82.73M |
| June 24, 2026 | 86.15M |
| June 23, 2026 | 85.46M |
| June 22, 2026 | 88.88M |
| June 18, 2026 | 82.73M |
| June 17, 2026 | 80.68M |
| June 16, 2026 | 86.15M |
| June 15, 2026 | 97.09M |
| June 12, 2026 | 105.29M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ocugen, Inc. | 481.44M |
| CytomX Therapeutics, Inc. | 734.32M |
| ACADIA Pharmaceuticals, Inc. | 5.240B |
| Alnylam Pharmaceuticals, Inc. | 32.07B |
| Anika Therapeutics, Inc. | 288.34M |
Market Cap Related Metrics
| PS Ratio | 136.31 |
| Price to Book Value | 2.634 |
| Price | 1.02 |
| Earnings Yield | -57.90% |